39健康

脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见

39健康网 专业医疗保健信息平台
优质健康资讯门户网站

脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见


参考资料:

[1]Herman, M.A., Metabolic liver disease — what’s in a name? Nature Reviews Endocrinology, 2020.

[2]Jelena Todoric et al. (2020) Fructose stimulated de novo lipogenesis is promoted by inflammation. Nature Metabolism

[3]Giovanni Targher, et al., (2021). Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. The Lancet Gastroenterology & Hepatology

[4]非酒精性脂肪性肝病防治指南(2018更新版)[J].传染病信息,2018,31(05):393-402+420.

[5]Parthasarathy, G. et al. “Pathogenesis of Nonalcoholic Steatohepatitis: An Overview.” Hepatology Communications 4 (2020): 478 - 492.

[6]Younossi, Z. et al. “Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.” Clinical Gastroenterology & Hepatology 17 (2019): 748–755.e3.

[7]Younossi, Z. et al. “Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.” Hepatology 69 (2019): n. pag.

[8]Younossi, Z. et al. “Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.” Transplantation (2019): n. pag.

[9]Harrison, S. et al. “NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.” Hepatology (Baltimore, Md.) 71 (2019): 1198 - 1212.

[10]Choi, Hannah S. J. et al. “Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B.” Hepatology 71 (2019): n. pag.

[11]Diehl, A. and Christopher Day. “Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.” The New England Journal of Medicine 377 (2017): 2063–2072.

[12]Kim, D. et al. “Predictors of nonalcoholic steatohepatitis and significant fibrosis in non‐obese nonalcoholic fatty liver disease.” Liver International 39 (2019): 332 - 341.

[13]Younossi, Z. et al. “Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.” Hepatology 68 (2018): n. pag.

63
2021-07-18浏览4866举报/反馈
本内容不能代替面诊,如有不适请尽快就医
展开全文
相关视频
相关图文
查看更多相关图文

相关科普

健康资讯热门资讯相关推荐文章推荐健康贴士
快速导航
频道
女性
减肥
育儿
保健
美容
妇科
饮食
中医
肿瘤
资讯
男性
诊疗
呼吸科
心血管
肝病科
更多
服务
问医生
就医助手
药品通
疾病百科
医生挂号
简单生活
热门疾病
高血压
阴道炎
肩周炎
脂肪肝
小儿咳嗽
糖尿病
健康科普
科普基地